Fixed scopes, starting with a re‑analysis pilot
Coarse scales, few visits, rater variation and phone changes hide drug effects. Cephalgo adds rater checks and readings on your scale, stable across phone changes, from audio you hold, site visits or home. Fixed fee.
Where you start
Four starting points. For rated interviews, Trial QC can also run on its own. Trial QC ›
Recordings from a past or ongoing trial
Your visit and interview audio has never been read for speech. You get readings on your scale, rater flags and variance components, and from a completed trial an effect size your statistician computes on the locked readings. No new collection. Re-analysis pilot ›
No audio yet
You get readings from the site’s own visit recordings and short home sessions, pre-specified in your SAP, so a change can be seen between scheduled visits. Home sessions run in your eCOA or app; ours only where none exists. Prospective study ›
Already using a speech vendor
You get a second reading on your existing audio, on the trial’s own scale, so a vendor-only finding can be confirmed before it drives a decision. Your vendor stays. Re-analysis pilot › Stability audit ›
Already running your own speech models
Keep your pipeline. You get readings on your scale and named features on the same audio, so you can test your own measures against them. Re-analysis pilot › Stability audit ›
Re-analysis pilot
Your completed or ongoing study already holds recorded speech. You get an extra measure from it and, from a completed trial, effect sizes for your next protocol, where consent covers further analysis. No new collection or protocol change.
On your scale
A reading per visit on the protocol’s scale. Calibrated on the study’s screening and baseline ratings, blind to arm, and locked before post-baseline recordings are read.
Joined to the visit score
Readings and visit scores in one table, visit by visit, ready for your statisticians.
Trial QC flags included
Where the recordings are rating interviews, Trial QC flags per rater and interview, as in the Trial QC scope.
Sample-size planning
From a completed study: variance components and an effect-size estimate, computed by your statistician on the locked readings. Cephalgo’s analysis team stays blind to arm.
- Recordings, or your authorization to their holder; Cephalgo drafts it
- Visit scores
- The consent scope
- Fee and timeline: fixed in writing before any data moves
Trial QC
Baseline inflation and rater drift add noise that reads as placebo response. For a trial whose endpoint is a rated interview, you get flags from screening onward, so your blinded team can act before randomization.
Flags per rater and interview
Each score checked against the recorded interview, the rater’s own other interviews, and other sites at the same visit type.
Before randomization
Screening interviews are read as they arrive, so a flag can reach your blinded team before randomization; baseline interviews are flagged by the next data transfer.
Flag rule fixed first
Set in writing before any audio is read. A between-arm check is pre-specified and run by an independent unblinded statistician; its results never reach the team that receives flags.
Who receives flags
Your blinded study team or central rating vendor, at each data transfer.
- Recorded rating interviews from your sites, eCOA or central rating vendor
- Your authorization to the recording holder; Cephalgo drafts it, sends a one-page file specification and coordinates retrieval
Prospective study
Few coarse visits leave little data for phase 2 decisions, including dose. For a protocol in design, you get site-visit and home readings per participant, pre‑specified in your SAP. Your team sees pooled readings; per‑arm readings stay in an unblinded view.
Capture specification
Recording tasks, cadence and consent wording, ready for the protocol and your eCOA or app vendor; our capture runs home sessions only where the study has none.
Exploratory endpoint
Pre-specified in your SAP; estimand, features and comparison drafted with your statisticians per ICH E9(R1).
Participants’ own devices
Readings recalibrated when a phone or its software changes. Device, software and app version where the recording app provides them; otherwise the processing period, read from the audio.
Into your systems
Readings by export, by API or into the study’s eCOA or EDC system.
- The draft protocol: phase, population and endpoint
Stability audit
Phones and their software change during a study, and a change can look like disease change. You get each reading checked and recalibrated across those changes, so readings from every device and software version sit on one scale.
Processing periods
Where, in each participant’s recordings, the phone or its software changes, from version data or read from the audio.
Stability per reading
How stable each reading and its named features are across those periods.
Original and recalibrated
Both sets of readings across the periods, recalibrated blind to arm, for your analysis.
Nothing new to collect
Runs on the recordings you already hold, within the consent they were collected under; no protocol change.
Pre-screening
Screen failures cost site time and budget. You get a reading against your entry criteria, recorded at home before the screening visit, so sites can book screening visits for candidates inside your entry range. The entry scale is set per program.
Entry range fixed first
Calibrated per study language on paired screening scores and recordings, and fixed in writing before the first candidate records.
Consent
Candidates consent to pre-screening, remotely where approved; trial consent stays at the screening visit. Recordings of those not invited are kept only as the protocol and consent specify.
Reading returned
To the site through the study dashboard, as set in the written scope. Any safety disclosure in a recording goes to the site, under your protocol’s safety procedure. Platform ›
Recording route
A browser on the candidate’s own phone, an automated or site-run phone call, or our app. A failed check gets a retake before the session ends. Recording routes ›
- 01Site
Refers and consents
Pre-screening consent, apart from trial consent
- 02Candidate
Records a few minutes
App, browser or phone call
- 03Cephalgo
Checks and reads
Against the entry range
- 04Cephalgo
Returns the reading
Before the site books the screening visit
- 05Site
Invites and screens
The site decides who is invited. The screening visit is unchanged.
- The program, the entry criteria and the number of sites
What each scope asks of sites and participants
What changes for participants and site staff, scope by scope. Where a scope adds work at sites, one remote training workshop comes before activation.
Request a scope| Scope | Participant | Site staff |
|---|---|---|
| Re-analysis pilot | Nothing new | Nothing new |
| Trial QCSites already recording | Nothing new | Nothing new |
| Trial QCSites not yet recording | Interview recorded under the protocol, with consent from participants and informants | Interview recording added, with one remote training workshop; the scale administered and scored as before |
| Prospective study | Site-visit recordings and short home sessions between visits, at the cadence the protocol sets | One remote training workshop; scale, raters and visit schedule unchanged |
| Stability audit | Nothing new | Nothing new |
| Pre-screeningSeparate scope | A few minutes at home, by app or browser on the candidate’s own device, or by a phone call | Refers and consents; may run the phone call; reviews readings outside the entry range |
What you hold at the end
Readings or Trial QC flags, versions and evidence in the formats your study already uses, with GDPR documents and records designed to support 21 CFR Part 11 in every scope.
Readings and flags
Readings per session or visit, and Trial QC flags per rater and interview, as CSV, Parquet or API, or into your eCOA or EDC; CDISC ODM, SDTM-aligned or your format.
Version record
Analysis version on every reading; device, software and app version where the recording app provides them, otherwise the processing period, read from the audio.
Analysis plan text
Estimand, features and comparison, fixed in writing before post‑baseline recordings are read; the Trial QC flag rule, before any audio is read.
Validation evidence
Each measure evaluated stage by stage following the DiMe V3 framework, one indication at a time, and your study’s validation report follows TRIPOD+AI. Validation approach ›
